Sponsor Pipeline

Neurimmune AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07213583 Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM Amyloid Transthyretin Cardiomyopathy Active, Not Recruiting
Get alerts when Neurimmune AG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free